EBMT at the 61st ASH Annual Meeting

Once again, the EBMT will be actively participating to the 61^st American Society of Hematology Meeting that will be held December 7-10, in Orlando, Florida, US.

The EBMT will present 30 communications in the different oral or posters sessions.
You will find below the list of these abstracts including title, time and location of presentations. You can click on the title to view the full abstract from the ASH website.

Congratulations to all co-authors and thank you all for your continuous support!

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Result Type: Paper
Number: 3281
Presenter: Annalisa Ruggeri
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center) 

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Result Type: Paper
Number: 2038
Presenter: Francesco Saraceni
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 7, 2019: 5:30 PM-7:30 PM
Hall B (Orange County Convention Center) 

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Result Type: Paper
Number: 3327
Presenter: Francesco Saraceni
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center) 

CD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using Peripheral Blood Stem Cells. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Result Type: Paper
Number: 4586
Presenter: Enrico Maffini
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center) 

BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society

Result Type: Paper
Number: 3313
Presenter: Riccardo Saccardi
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center) 

Comparison of a New Reduced Toxicity Myeloablative Treosulfan and Fludarabine Preparative Regimen with Myeloablative Busulfan or Melphalan in Combination with Fludarabine in Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes: A Retrospective Matched Pair Analysis of Patients from a Prospective Randomized Trial and the European Blood and Marrow Transplantation Society Registry

Result Type: Paper
Number: 3326
Presenter: Dietrich Beelen
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center) 

Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome: A Large Series from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Result Type: Paper
Number: 2053
Presenter: Olivier Tournilhac
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 7, 2019: 5:30 PM-7:30 PM
Hall B (Orange County Convention Center) 

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Result Type: Paper
Number: 44
Presenter: Maurizio Miano
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Predicting Results
Time and Location:
Saturday, December 7, 2019: 7:30 AM-9:00 AM
W331 (Orange County Convention Center) 

Bone Marrow Versus Mobilized Peripheral Blood Stem Cells for Non T Depleted Haploidentical Transplantations with Post Transplantation Cyclophosphamide in Acute Lymphoblastic Leukemia: On Behalf of the ALWP of the EBMT

Result Type: Paper
Number: 589
Presenter: Arnon Nagler
Program: Oral and Poster Abstracts
Session: 711. Cell Collection and Processing
Time and Location:
Monday, December 9, 2019: 7:00 AM-8:30 AM
W414AB (Orange County Convention Center) 

Outcome of Two Loci Mismatched (≤6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study

Result Type: Paper
Number: 4604
Presenter: Arnon Nagler
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Results of Unrelated Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Europe on Behalf of Paediatric Diseases (PDWP) and Inborn Errors Working Parties (IEWP) of the EBMT

Result Type: Paper
Number: 4583
Presenter: Eliane Gluckman
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

Result Type: Paper
Number: 4581
Presenter: Marie Robin
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

Result Type: Paper
Number: 43
Presenter: Roni Shouval
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Predicting Results
Time and Location:
Saturday, December 7, 2019: 7:30 AM-9:00 AM
W331 (Orange County Convention Center) 

A Multi-Center, Multinational, Prospective Observational Registry Study of Defibrotide in Patients Diagnosed with Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT)

Result Type: Paper
Number: 1972
Presenter: Mohamad Mohty
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 7, 2019: 5:30 PM-7:30 PM
Hall B (Orange County Convention Center)

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Result Type: Paper
Number: 4483
Presenter: Abdul Hamid Bazarbachi
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients – the Diadem Study from the Chronic Malignancies Working Party of the EBMT

Result Type: Paper
Number: 4574
Presenter: Anna Waszczuk-Gajda
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Result Type: Paper
Number: 45
Presenter: Marie Robin
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Predicting Results
Time and Location:
Saturday, December 7, 2019: 7:30 AM-9:00 AM
W331 (Orange County Convention Center)

Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT

Result Type: Paper
Number: 3335
Presenter: Donal McLornan
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017

Result Type: Paper
Number: 4575
Presenter: Stefan Schönland
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Comparison of Mycophenolate Mofetil and a Calcineurin Inhibitor Versus Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylaxis for Matched Unrelated Donor Transplant for Acute Myeloid Leukemia. a Study from the ALWP of the EBMT

Result Type: Paper
Number: 4548
Presenter: Annalisa Paviglianiti
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Lymphoblastic Leukemia: ALWP of the EBMT Study

Result Type: Paper
Number: 320
Presenter: Bhagirathbhai Dholaria
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Comparative Analyses
Time and Location:
Saturday, December 7, 2019: 4:00 PM-5:30 PM
W307 (Orange County Convention Center)

From Ex-Vivo T-Cell Depletion to Post-Transplant Cyclophosphamide: Improved GvHD-Free & Relapse-Free Survival but Comparable Chronic GvHD Incidence in Haploidentical Transplantation. A 15 Years EBMT Registry Analysis on Behalf of the TCWP-EBMT

Result Type: Paper
Number: 876
Presenter: Maria Teresa Lupo-Stanghellini
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Mechanisms of and Therapies for cGVHD
Time and Location:
Monday, December 9, 2019: 4:30 PM-6:00 PM
W230 (Orange County Convention Center)

Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT

Result Type: Paper
Number: 698
Presenter: Mitja Nabergoj
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Outcomes and Late Effects
Time and Location:
Monday, December 9, 2019: 10:30 AM-12:00 PM
W304EFGH (Orange County Convention Center)

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

Result Type: Paper
Number: 3274
Presenter: Jaime Sanz
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Result Type: Paper
Number: 148
Presenter: Giorgia Battipaglia
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Alternative Donors, Novel Regimens
Time and Location:
Saturday, December 7, 2019: 9:30 AM-11:00 AM
W307 (Orange County Convention Center)

Comparison of Different Upfront Transplant Strategies in Multiple Myeloma - a Large Registry Study from Chronic Malignancies Working Party of EBMT

Result Type: Paper
Number: 324
Presenter: Stefan Schönland
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Comparative Analyses
Time and Location:
Saturday, December 7, 2019: 4:00 PM-5:30 PM
W307 (Orange County Convention Center)

Reduced Risk of Relapse for Total Body Irradiation + Fludarabine Compared to Busulphan + Fludarabine As “Reduced-Toxicity” Conditioning for Patients with Acute Myeloid Leukemia Treated with Allohsct in First Complete Remission. a Study By the Acute Leukemia Working Party of the EBMT

Result Type: Paper
Number: 255
Presenter: Sebastian Giebel
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Conditioning Intensity in Allogeneic Transplantation--Does It Matter?
Time and Location:
Saturday, December 7, 2019: 2:00 PM-3:30 PM
W331 (Orange County Convention Center)

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Result Type: Paper
Number: 3338
Presenter: Tomasz Czerw
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)

Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 – a Retrospective Study from the LWP-EBMT

Result Type: Paper
Number: 701
Presenter: Claire Burney
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Outcomes and Late Effects
Time and Location:
Monday, December 9, 2019: 10:30 AM-12:00 PM
W304EFGH (Orange County Convention Center)

Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Result Type: Paper
Number: 4018
Presenter: Nikesh Chavda
Program: Oral and Poster Abstracts
Session: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Poster III
Time and Location:
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B (Orange County Convention Center)